文献速递生殖医学

在PGT-A和常规IVF/ICSI周期中,囊胚腔液未检测到DNA与更高的活产率相关

Failure to detect DNA in blastocoel fluid is associated with a higher live birth rate in both PGT-A and conventional IVF/ICSI cycles.
PubMed 文献 · Hum Reprod · 2023-01-01

前瞻性队列研究纳入102例PGT-A患者和88例常规IVF/ICSI患者,首次移植时囊胚腔液全基因组扩增(BF-WGA)阴性囊胚的活产率在两组均显著高于阳性囊胚,调整混杂后OR分别为3.52和6.89。

要点

  • PGT-A组首次移植BF-WGA阴性囊胚活产率53.3%,阳性囊胚26.2%(P=0.0081)。
  • 常规IVF/ICSI组首次移植BF-WGA阴性囊胚活产率48.4%,阳性囊胚11.5%(P=0.0014)。
  • BF-WGA阴性囊胚移植的活产率在PGT-A组OR 3.52(95%CI 1.48-8.88),常规组OR 6.89(95%CI 1.98-32.95)。

核心结论

  • 首次移植时,BF-WGA阴性囊胚较阳性囊胚有更多植入并发育至足月机会,在PGT-A和常规IVF/ICSI周期均如此。
  • BF-WGA处理简单且成本效益好,可能成为让患者在最短时间内获得最高足月妊娠机会的有价值选项。

研究设计与样本

  • 前瞻性队列研究,2019年1月至2021年12月纳入102例连续PGT-A患者(组1)和88例连续常规IVF/ICSI患者(组2)。
  • 两组均从高质量扩张囊胚收集囊胚腔液并行WGA,琼脂糖凝胶电泳判断有无条带(阳性/阴性BF-WGA)。
  • 组1囊胚取BF后立即行滋养外胚层活检并玻璃化,仅移植整倍体囊胚;组2取BF后立即玻璃化。
  • 两组移植囊胚选择优先考虑BF-WGA阴性者;主要结局为首次移植活产率,主要变量为BF-WGA阴性,采用多元逻辑回归校正母方及父方年龄、获卵数、男方因素等混杂因素。

主要发现

  • 组1中60例移植BF-WGA阴性囊胚、42例移植阳性囊胚,首次移植活产率分别为53.3%和26.2%(P=0.0081)。
  • 组1多元逻辑分析显示,移植BF-WGA阴性囊胚较阳性囊胚的OR为3.52(95%CI 1.48-8.88,P=0.0057)。
  • 组2中首次移植BF-WGA阴性囊胚30例分娩(48.4%),26例患者移植阳性囊胚3例分娩(11.5%;P=0.0014)。
  • 组2多元逻辑分析显示,移植BF-WGA阴性囊胚较阳性囊胚的OR为6.89(95%CI 1.98-32.95,P=0.0056)。
  • 每移植活产率和每患者累积活产率显示相同趋势。

临床怎么用

  • 本研究数据强调,即使经滋养外胚层分析分类为整倍体,形态相似的囊胚仍存在异质性。
  • BF-WGA未检测到DNA与首次胚胎移植、每移植及每患者更高的活产率显著相关。
  • 作者认为BF-WGA处理简单且成本效益好,可能成为让患者在最短时间内获得最高足月妊娠机会的有价值选项。

局限性

  • 本研究在单中心进行。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is the presence of DNA in the blastocoel fluid (BF) of expanded blastocysts, assessed by whole genome amplification (WGA), associated with the clinical outcome at the first transfer? SUMMARY ANSWER: At the first transfer, blastocysts with negative BF-WGA have more chance to implant and to develop to term than those with positive BF-WGA results, both in preimplantation genetic testing for aneuploidies (PGT-A) cycles (where only euploid blastocysts resulting from the chromosomal analysis of trophectoderm (TE) biopsies were transferred) and in IVF/ICSI conventional cycles. WHAT IS KNOWN ALREADY: Retrospective studies conducted in patients undergoing PGT-A have shown that the incidence of negative BF-WGA was significantly higher in TE-euploid blastocysts than in TE-aneuploid blastocysts. In addition, after the transfer of TE-euploid blastocysts, the ongoing clinical pregnancy rate was significantly higher in the group with negative BF-WGA compared with those with positive BF-WGA. STUDY DESIGN, SIZE, DURATION: A prospective cohort study including 102 consecutive PGT-A patients (Group 1) and 88 consecutive conventional IVF/ICSI patients (Group 2), was conducted between January 2019 and December 2021. PARTICIPANTS/MATERIALS, SETTING, METHODS: In both groups, BFs were collected from expanded blastocysts of high grade and processed for WGA. DNA amplification was evaluated by agarose gel electrophoresis for the presence (positive BF-WGA) or absence (negative BF-WGA) of a band. Directly after the BF retrieval, blastocysts from Group 1 underwent TE biopsy and vitrification. In Group 2, blastocysts were vitrified immediately after BF collection. In Group 1, only euploid blastocysts were considered for transfer according to the results of TE biopsies. In both groups, the selection of the blastocyst to be transferred was based on BF-WGA results giving priority, if available, to those with negative amplification. The primary outcome investigated was the live birth rate (LBR) at the first transfer. The main variable under investigation was the negative BF-WGA and results were corrected for confounders (maternal and paternal age, number of retrieved oocytes, male factor) by multiple logistic regression analysis. MAIN RESULTS AND THE ROLE OF CHANCE: In Group 1, 60 patients transferred negative BF-WGA blastocysts and 42 positive BF-WGA blastocysts, and the LBR at the first transfer was 53.3% and 26.2%, respectively (P = 0.0081). After testing for selected confounders in a multiple logistic analysis, the transfer of blastocysts with negative BF-WGA resulted in an odds ratio of (OR) 3.52 (95% CI: 1.48-8.88, P = 0.0057) compared to transfer of positive BF-WGA blastocysts. In Group 2, at the first transfer 30 deliveries resulted from blastocysts with negative BF-WGA (48.4%) and three from the transfer of positive BF-WGA blastocysts in 26 patients (11.5%; P = 0.0014). Multiple logistic analysis indicated that the transfer of blastocysts with negative BF-WGA resulted in an OR 6.89 (95% CI: 1.98-32.95, P = 0.0056) compared to transfer of positive BF-WGA blastocysts. The LBR per transfer and the cumulative LBR per patient showed the same trend. LIMITATIONS, REASONS FOR CAUTION: The study was performed in a single center. WIDER IMPLICATIONS OF THE FINDINGS: The data from this study highlight the heterogeneity of blastocysts of similar morphology, even in those classified as euploid by TE analysis. Failure to detect DNA in BFs after WGA is associated with a significantly higher LBR at the first embryo transfer as well as per transfer and per patient. The processing of the BF by WGA is an easy and cost-effective tool that could become a valuable option to offer patients the highest chances of term pregnancy in the shortest time possible. STUDY FUNDING/COMPETING INTEREST(S): The study received no funding from external sources. There are no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Gianaroli L, Perruzza D, Albanese C, et al. Failure to detect DNA in blastocoel fluid is associated with a higher live birth rate in both PGT-A and conventional IVF/ICSI cycles. Hum Reprod. 2023. PMID: 37159504. doi:10.1093/humrep/dead088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。